302 EAST PETTIGREW STREET, DURHAM, NC
Market cap: $59.5M (12/18/2025)
Price: $4.49
Precision BioSciences Enters Underwriting Agreement for Stock Offering
Precision BioSciences Presents Phase 1 PBGENE-HBV Data Showing Antiviral Activity
Reports Third Quarter 2025 Financial Results and Provides Business Update
Changes in Board, Management or Compensation
Earnings Release
Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B
Shareholder votes
Reports First Quarter 2025 Financial Results and Provides Business Update
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Free Writing Prospectus